Rani Therapeutics Holdings Inc - Class A —— 季度现金流量表 (NASDAQ:RANI) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 36.63 M24.13 M16.9 M10.14 M58.62 M 负债总额 33.14 M29.47 M26.05 M22.11 M17.11 M 权益总额 3.49 M-5.35 M-9.15 M-11.97 M41.51 M 负债及股东权益总额 36.63 M24.13 M16.9 M10.14 M58.62 M 总债务 24.61 M20.92 M17.23 M13.54 M0 净债务 20.85 M10.81 M7.01 M9.39 M-18.62 M

新闻

Rani Therapeutics Holdings, Inc. (RANI) Q4 2025 Earnings Call Transcript

Rani Therapeutics任命Alireza Javadi为首席技术官

Rani Therapeutics promotes Alireza Javadi to chief technical officer

Rani Therapeutics begins phase 1 trial of oral obesity treatment

Rani Therapeutics修改公司章程，降低B类股投票权并终止税务协议

Rani Therapeutics amends charter, reduces Class B voting power and ends tax agreement

Rani Therapeutics宣布与中外制药达成价值10.85亿美元合作协议

Rani Therapeutics announces $1.085 billion Chugai collaboration

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.09%

美国股市上涨；截至收盘道琼斯工业平均指数上涨0.09%

Monday’s Insider Moves: Top Buys and Sells in US Stocks on October 27

Rani Therapeutics董事Imran Mir A购入价值126万美元股票